Lowering HbA1c in type 2 diabetics results in reduced risk of coronary heart disease and all-cause mortality

Primary Care Diabetes

Volumn 2, Issue 1, 2008, Pages 45-49

  ten Brinke, Rien ^a   Dekker, Nicky ^a   de Groot, Marjolein ^a   Ikkersheim, David ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Coronary heart disease; Diabetes mellitus type 2; HbA1c; Mortality

Indexed keywords

EID: 40149097892     PISSN: 17519918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcd.2007.12.004     Document Type: Article

References (20)

1. E. Selvin S. Marinopoulos G. Berkenblit Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus Ann. Intern. Med. 141 2004 421 431
2. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N. Eng. J. Med. 329 1993 977 986
3. UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 317 1998 703 712
4. The Dutch Cochrane Collaboration, Checklist “Cohort” and “SR-Obs”, 2003, www.cochrane.nl .
5. Levels of evidence: http://www.cebm.net/levels_of_evidence.asp#levels .
6. E. Selvin S. Marinopoulos G. Berkenblit Meta analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus Ann. Intern. Med. 141 2004 421 431
7. M. Laakso Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies Ann. Intern. Med. 124 1996 127 130
8. P.T. Donnan L. Donnelly J.P. New A.D. Morris Derivation and validation of a prediction score for major coronary heart disease events in a UK type 2 diabetic population Diabetes Care 29 2006 1231 1236
9. A.I. Adler H.A. Neil S.E. Manley Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47) Am. Heart J. 138 1999 353 359
10. I.M. Stratton A.I. Adler H.A. Neil Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 2000 405 412
11. I.M. Stratton C.A. Cull A.I. Adler Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75) Diabetologia 49 2006 1761 1769
12. E. Selvin J. Coresh S.H. Golden Glycemic control and coronary heart disease risk in persons with and without diabetes Arch. Intern. Med. 165 2005 1910 1916
13. M.S. Kirkman M. McCarren J. Shah The association between metabolic control and prevalent macrovascular disease in type 2 diabetes: the VA cooperative study in diabetes J. Diab. Compl. 20 2006 75 80
14. E. Standl B. Balletshofer B. Dahl Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project Diabetologia 39 1996 1540 1545
15. H.C. Gerstein J. Pogue J.F. Mann The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis Diabetologia 48 2005 1749 1755
16. M. Massi-Benedetti Changing targets in the treatment of type 2 diabetes Curr. Med. Res. Opin. 22 2006 S5 S13
17. American Diabetes Association Standards of medical care in diabetes—2006 Diabetes Care 29 Suppl. 1 2006 S4 S42
18. International Diabetes Federation Clinical Guidelines Taskforce, Global Guideline for Type 2 Diabetes, International Diabetes Federation, Brussels, 2005.
19. A. McIntosh A. Hutchinson P.D. Home Clinical Guidelines and Evidence Review for Type 2 Diabetes: Blood Glucose Management 2001 ScHARR, University of Sheffield Sheffield
20. G.E.H.M. Rutten W.J.C. de Grauw G. Nijpels A.N. Goudswaard Practice guideline diabetes mellitus type 2 Huisarts Wet 49 2006 137 152